TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 75 filers reported holding TRANSLATE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $100,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,833,120 | $52,169,000 | 8.78% |
| Copernicus Capital Management, LLC | 227,719 | $3,099,000 | 2.95% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $29,708,000 | 2.67% |
| Baupost Group | 18,044,239 | $242,393,000 | 2.62% |
| Prosight Management, LP | 282,100 | $3,839,000 | 1.83% |
| RTW INVESTMENTS, LP | 3,745,286 | $50,973,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 943,339 | $12,839,000 | 1.16% |
| DAFNA Capital Management LLC | 190,930 | $2,599,000 | 0.84% |
| Endurant Capital Management LP | 176,710 | $2,405,000 | 0.71% |
| Artal Group S.A. | 1,400,000 | $19,054,000 | 0.46% |